SS Innovations Subsidiary Graduates First Cardiac Robotic Surgery Training Class, Expanding Access to Robotic Surgery

SS Innovations International, Inc. (NASDAQ: SSII) announced that its subsidiary, the SS International Centre for Robotics Surgery (SSICRS), has successfully graduated the inaugural class of its Cardiac Robotic Surgery Training program. The five-day intensive course brought together 33 participants from seven countries and 16 international faculty members for classroom instruction, live surgical demonstrations, and hands-on training using the company’s SSi Mantra surgical robotic system.

This milestone marks a significant step in making robotic-assisted surgery more accessible worldwide. By training surgeons from multiple countries, SS Innovations is helping to bridge the gap in surgical expertise, particularly in regions where advanced surgical technologies are scarce. The SSi Mantra system is designed to be cost-effective and user-friendly, aligning with the company’s vision to democratize robotic surgery.

SSICRS plans to expand its educational offerings through additional condensed training programs covering multiple surgical specialties, including urology, gynecology, thoracic, colorectal, gastrointestinal, and general surgery. The training center combines modern lecture facilities, advanced simulation labs, tele-proctoring, and online learning modules to support surgeon education and the broader adoption of robotic-assisted surgery. This comprehensive approach ensures that surgeons receive both theoretical knowledge and practical experience, which is critical for patient safety and successful outcomes.

The implications of this announcement are far-reaching. For the healthcare industry, the expansion of training programs could accelerate the adoption of robotic surgery, leading to less invasive procedures, reduced recovery times, and improved patient outcomes. For Texas, where the company is headquartered, this positions the state as a hub for medical technology innovation and training. The economic impact includes potential job creation in the medical device sector and enhanced reputation for Texas-based healthcare institutions.

SS Innovations International, Inc. (NASDAQ: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced solutions.

For more information on the full press release, visit https://ibn.fm/7oFgo. To stay updated on the latest news and updates relating to SSII, visit the company’s newsroom at https://ibn.fm/SSII.